Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Occurrence of Autoimmune Diseases Related to the Vaccine against Yellow Fever.
Regression to the Mean and Predictors of MRI Disease Activity in RRMS Placebo Cohorts - Is There a Place for Baseline-to-Treatment Studies in MS?
Implications for multiple sclerosis in the era of the Affordable Care Act: an evolving treatment paradigm.
Targeting autophagy as a potential therapeutic approach for immune thrombocytopenia therapy.
A novel synthetic compound MCAP suppresses LPS-induced murine microglial activation in vitro via inhibiting NF-kB and p38 MAPK pathways.
Increase in multiple sclerosis activity after assisted reproduction technology.
Inadequacy of Clinical Trial Designs and Data to Control for the Confounding Impact of Race/Ethnicity in Response to Treatment in Multiple Sclerosis.
Bisphenol-A Impairs Myelination Potential During Development in the Hippocampus of the Rat Brain.
Relative changes in ankle and hip control during bilateral joint movements in persons with multiple sclerosis.
C9ORF72 repeat expansion not detected in patients with multiple sclerosis.
The MoSt Project--More Steps in multiple sclerosis: a Delphi method consensus initiative for the evaluation of mobility management of MS patients in Italy.
Restless legs syndrome as the initial presentation of multiple sclerosis.
Decoding the substrate supply to human neuronal nitric oxide synthase.
Evaluation of the Persian version of modified fatigue impact scale in Iranian patients with multiple sclerosis.
The neurotrophic hepatocyte growth factor attenuates CD8+ cytotoxic T-lymphocyte activity.
The NLR family member, NLRX1, mediates protection against experimental autoimmune encephalomyelitis and represses macrophage/microglial-induced inflammation.
Purinergic mechanisms in neuroinflammation: An update from molecules to behavior.
The azetidine derivative, KHG26792 protects against ATP-induced activation of NFAT and MAPK pathways through P2X7 receptor in microglia.
RNA processing-associated molecular mechanisms of neurodegenerative diseases.
Therapeutic Potential of the Modulation of Sphingosine 1 phosphate receptors.
Serial electrophysiological studies in a Guillain-Barré subtype with bilateral facial neuropathy.
Evaluation and Treatment of Autoimmune Neurologic Disorders in the Pediatric Intensive Care Unit.
Diagnoses in Pediatric Patients With Magnetic Resonance Imaging (MRI) Lesions Suspicious for Demyelination.
Blood B Cell and Regulatory Subset Content in Multiple Sclerosis Patients.
The Perspectives of Mesenchymal Stem Cell Therapy in the Treatment of Multiple Sclerosis.

Pages